Vaccines-Europe Market Status and Trend Report 2013-2023
Report Summary
Vaccines-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vaccines industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Vaccines 2013-2017, and development forecast 2018-2023
Main market players of Vaccines in Europe, with company and product introduction, position in the Vaccines market
Market status and development trend of Vaccines by types and applications
Cost and profit status of Vaccines, and marketing status
Market growth drivers and challenges
The report segments the Europe Vaccines market as:
Europe Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Other
Europe Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Adult
Children
Europe Vaccines Market: Players Segment Analysis (Company and Product introduction, Vaccines Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Vaccines-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vaccines industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Vaccines 2013-2017, and development forecast 2018-2023
Main market players of Vaccines in Europe, with company and product introduction, position in the Vaccines market
Market status and development trend of Vaccines by types and applications
Cost and profit status of Vaccines, and marketing status
Market growth drivers and challenges
The report segments the Europe Vaccines market as:
Europe Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Other
Europe Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Adult
Children
Europe Vaccines Market: Players Segment Analysis (Company and Product introduction, Vaccines Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF VACCINES
1.1 Definition of Vaccines in This Report
1.2 Commercial Types of Vaccines
1.2.1 Recombinant Vaccines
1.2.2 Viral Vaccines
1.2.3 Polysaccharide Vaccines
1.2.4 Other
1.3 Downstream Application of Vaccines
1.3.1 Adult
1.3.2 Children
1.4 Development History of Vaccines
1.5 Market Status and Trend of Vaccines 2013-2023
1.5.1 Europe Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Vaccines Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Vaccines in Europe 2013-2017
2.2 Consumption Market of Vaccines in Europe by Regions
2.2.1 Consumption Volume of Vaccines in Europe by Regions
2.2.2 Revenue of Vaccines in Europe by Regions
2.3 Market Analysis of Vaccines in Europe by Regions
2.3.1 Market Analysis of Vaccines in Germany 2013-2017
2.3.2 Market Analysis of Vaccines in United Kingdom 2013-2017
2.3.3 Market Analysis of Vaccines in France 2013-2017
2.3.4 Market Analysis of Vaccines in Italy 2013-2017
2.3.5 Market Analysis of Vaccines in Spain 2013-2017
2.3.6 Market Analysis of Vaccines in Benelux 2013-2017
2.3.7 Market Analysis of Vaccines in Russia 2013-2017
2.4 Market Development Forecast of Vaccines in Europe 2018-2023
2.4.1 Market Development Forecast of Vaccines in Europe 2018-2023
2.4.2 Market Development Forecast of Vaccines by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Vaccines in Europe by Types
3.1.2 Revenue of Vaccines in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Vaccines in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Vaccines in Europe by Downstream Industry
4.2 Demand Volume of Vaccines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Vaccines by Downstream Industry in Germany
4.2.2 Demand Volume of Vaccines by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Vaccines by Downstream Industry in France
4.2.4 Demand Volume of Vaccines by Downstream Industry in Italy
4.2.5 Demand Volume of Vaccines by Downstream Industry in Spain
4.2.6 Demand Volume of Vaccines by Downstream Industry in Benelux
4.2.7 Demand Volume of Vaccines by Downstream Industry in Russia
4.3 Market Forecast of Vaccines in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VACCINES
5.1 Europe Economy Situation and Trend Overview
5.2 Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 6 VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Vaccines in Europe by Major Players
6.2 Revenue of Vaccines in Europe by Major Players
6.3 Basic Information of Vaccines by Major Players
6.3.1 Headquarters Location and Established Time of Vaccines Major Players
6.3.2 Employees and Revenue Level of Vaccines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GSK
7.1.1 Company profile
7.1.2 Representative Vaccines Product
7.1.3 Vaccines Sales, Revenue, Price and Gross Margin of GSK
7.2 Sanofi
7.2.1 Company profile
7.2.2 Representative Vaccines Product
7.2.3 Vaccines Sales, Revenue, Price and Gross Margin of Sanofi
7.3 Merck
7.3.1 Company profile
7.3.2 Representative Vaccines Product
7.3.3 Vaccines Sales, Revenue, Price and Gross Margin of Merck
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative Vaccines Product
7.4.3 Vaccines Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Novartis(GSK)
7.5.1 Company profile
7.5.2 Representative Vaccines Product
7.5.3 Vaccines Sales, Revenue, Price and Gross Margin of Novartis(GSK)
7.6 CSL
7.6.1 Company profile
7.6.2 Representative Vaccines Product
7.6.3 Vaccines Sales, Revenue, Price and Gross Margin of CSL
7.7 MedImmune
7.7.1 Company profile
7.7.2 Representative Vaccines Product
7.7.3 Vaccines Sales, Revenue, Price and Gross Margin of MedImmune
7.8 J&J(Crucell)
7.8.1 Company profile
7.8.2 Representative Vaccines Product
7.8.3 Vaccines Sales, Revenue, Price and Gross Margin of J&J(Crucell)
7.9 China National Biotec
7.9.1 Company profile
7.9.2 Representative Vaccines Product
7.9.3 Vaccines Sales, Revenue, Price and Gross Margin of China National Biotec
7.10 Tiantan
7.10.1 Company profile
7.10.2 Representative Vaccines Product
7.10.3 Vaccines Sales, Revenue, Price and Gross Margin of Tiantan
7.11 Hualan
7.11.1 Company profile
7.11.2 Representative Vaccines Product
7.11.3 Vaccines Sales, Revenue, Price and Gross Margin of Hualan
7.12 Kangtai
7.12.1 Company profile
7.12.2 Representative Vaccines Product
7.12.3 Vaccines Sales, Revenue, Price and Gross Margin of Kangtai
7.13 Hissen
7.13.1 Company profile
7.13.2 Representative Vaccines Product
7.13.3 Vaccines Sales, Revenue, Price and Gross Margin of Hissen
7.14 Jintan
7.14.1 Company profile
7.14.2 Representative Vaccines Product
7.14.3 Vaccines Sales, Revenue, Price and Gross Margin of Jintan
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VACCINES
8.1 Industry Chain of Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VACCINES
9.1 Cost Structure Analysis of Vaccines
9.2 Raw Materials Cost Analysis of Vaccines
9.3 Labor Cost Analysis of Vaccines
9.4 Manufacturing Expenses Analysis of Vaccines
CHAPTER 10 MARKETING STATUS ANALYSIS OF VACCINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Vaccines in This Report
1.2 Commercial Types of Vaccines
1.2.1 Recombinant Vaccines
1.2.2 Viral Vaccines
1.2.3 Polysaccharide Vaccines
1.2.4 Other
1.3 Downstream Application of Vaccines
1.3.1 Adult
1.3.2 Children
1.4 Development History of Vaccines
1.5 Market Status and Trend of Vaccines 2013-2023
1.5.1 Europe Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Vaccines Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Vaccines in Europe 2013-2017
2.2 Consumption Market of Vaccines in Europe by Regions
2.2.1 Consumption Volume of Vaccines in Europe by Regions
2.2.2 Revenue of Vaccines in Europe by Regions
2.3 Market Analysis of Vaccines in Europe by Regions
2.3.1 Market Analysis of Vaccines in Germany 2013-2017
2.3.2 Market Analysis of Vaccines in United Kingdom 2013-2017
2.3.3 Market Analysis of Vaccines in France 2013-2017
2.3.4 Market Analysis of Vaccines in Italy 2013-2017
2.3.5 Market Analysis of Vaccines in Spain 2013-2017
2.3.6 Market Analysis of Vaccines in Benelux 2013-2017
2.3.7 Market Analysis of Vaccines in Russia 2013-2017
2.4 Market Development Forecast of Vaccines in Europe 2018-2023
2.4.1 Market Development Forecast of Vaccines in Europe 2018-2023
2.4.2 Market Development Forecast of Vaccines by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Vaccines in Europe by Types
3.1.2 Revenue of Vaccines in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Vaccines in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Vaccines in Europe by Downstream Industry
4.2 Demand Volume of Vaccines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Vaccines by Downstream Industry in Germany
4.2.2 Demand Volume of Vaccines by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Vaccines by Downstream Industry in France
4.2.4 Demand Volume of Vaccines by Downstream Industry in Italy
4.2.5 Demand Volume of Vaccines by Downstream Industry in Spain
4.2.6 Demand Volume of Vaccines by Downstream Industry in Benelux
4.2.7 Demand Volume of Vaccines by Downstream Industry in Russia
4.3 Market Forecast of Vaccines in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VACCINES
5.1 Europe Economy Situation and Trend Overview
5.2 Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 6 VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Vaccines in Europe by Major Players
6.2 Revenue of Vaccines in Europe by Major Players
6.3 Basic Information of Vaccines by Major Players
6.3.1 Headquarters Location and Established Time of Vaccines Major Players
6.3.2 Employees and Revenue Level of Vaccines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GSK
7.1.1 Company profile
7.1.2 Representative Vaccines Product
7.1.3 Vaccines Sales, Revenue, Price and Gross Margin of GSK
7.2 Sanofi
7.2.1 Company profile
7.2.2 Representative Vaccines Product
7.2.3 Vaccines Sales, Revenue, Price and Gross Margin of Sanofi
7.3 Merck
7.3.1 Company profile
7.3.2 Representative Vaccines Product
7.3.3 Vaccines Sales, Revenue, Price and Gross Margin of Merck
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative Vaccines Product
7.4.3 Vaccines Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Novartis(GSK)
7.5.1 Company profile
7.5.2 Representative Vaccines Product
7.5.3 Vaccines Sales, Revenue, Price and Gross Margin of Novartis(GSK)
7.6 CSL
7.6.1 Company profile
7.6.2 Representative Vaccines Product
7.6.3 Vaccines Sales, Revenue, Price and Gross Margin of CSL
7.7 MedImmune
7.7.1 Company profile
7.7.2 Representative Vaccines Product
7.7.3 Vaccines Sales, Revenue, Price and Gross Margin of MedImmune
7.8 J&J(Crucell)
7.8.1 Company profile
7.8.2 Representative Vaccines Product
7.8.3 Vaccines Sales, Revenue, Price and Gross Margin of J&J(Crucell)
7.9 China National Biotec
7.9.1 Company profile
7.9.2 Representative Vaccines Product
7.9.3 Vaccines Sales, Revenue, Price and Gross Margin of China National Biotec
7.10 Tiantan
7.10.1 Company profile
7.10.2 Representative Vaccines Product
7.10.3 Vaccines Sales, Revenue, Price and Gross Margin of Tiantan
7.11 Hualan
7.11.1 Company profile
7.11.2 Representative Vaccines Product
7.11.3 Vaccines Sales, Revenue, Price and Gross Margin of Hualan
7.12 Kangtai
7.12.1 Company profile
7.12.2 Representative Vaccines Product
7.12.3 Vaccines Sales, Revenue, Price and Gross Margin of Kangtai
7.13 Hissen
7.13.1 Company profile
7.13.2 Representative Vaccines Product
7.13.3 Vaccines Sales, Revenue, Price and Gross Margin of Hissen
7.14 Jintan
7.14.1 Company profile
7.14.2 Representative Vaccines Product
7.14.3 Vaccines Sales, Revenue, Price and Gross Margin of Jintan
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VACCINES
8.1 Industry Chain of Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VACCINES
9.1 Cost Structure Analysis of Vaccines
9.2 Raw Materials Cost Analysis of Vaccines
9.3 Labor Cost Analysis of Vaccines
9.4 Manufacturing Expenses Analysis of Vaccines
CHAPTER 10 MARKETING STATUS ANALYSIS OF VACCINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
